Trexquant Investment’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.52M Buy
551,430
+101,809
+23% +$650K 0.04% 663
2025
Q1
$2.19M Sell
449,621
-251,896
-36% -$1.22M 0.03% 838
2024
Q4
$6.71M Buy
701,517
+261,099
+59% +$2.5M 0.08% 405
2024
Q3
$3.68M Buy
+440,418
New +$3.68M 0.05% 594
2023
Q2
Sell
-62,698
Closed -$650K 1522
2023
Q1
$650K Buy
+62,698
New +$650K 0.02% 890
2022
Q4
Sell
-30,089
Closed -$632K 1449
2022
Q3
$632K Buy
30,089
+14,412
+92% +$303K 0.02% 713
2022
Q2
$487K Sell
15,677
-32,159
-67% -$999K 0.02% 837
2022
Q1
$1.96M Buy
+47,836
New +$1.96M 0.09% 266
2021
Q4
Sell
-14,000
Closed -$701K 1377
2021
Q3
$701K Buy
+14,000
New +$701K 0.06% 413
2021
Q2
Sell
-3,942
Closed -$366K 1183
2021
Q1
$366K Buy
+3,942
New +$366K 0.03% 655
2020
Q4
Sell
-17,221
Closed -$1.78M 1124
2020
Q3
$1.78M Buy
+17,221
New +$1.78M 0.11% 248
2020
Q2
Sell
-8,861
Closed -$513K 1216
2020
Q1
$513K Buy
+8,861
New +$513K 0.04% 648
2018
Q1
Sell
-10,635
Closed -$494K 1144
2017
Q4
$494K Buy
+10,635
New +$494K 0.05% 516
2017
Q1
Sell
-6,111
Closed -$201K 1135
2016
Q4
$201K Buy
+6,111
New +$201K 0.03% 820
2016
Q2
Sell
-10,900
Closed -$396K 925
2016
Q1
$396K Buy
+10,900
New +$396K 0.05% 648
2015
Q3
Sell
-8,600
Closed -$283K 1084
2015
Q2
$283K Sell
8,600
-23,600
-73% -$777K 0.03% 831
2015
Q1
$926K Buy
+32,200
New +$926K 0.09% 406